Captrust Financial Advisors Purchases 12,079 Shares of Nutrien Ltd. $NTR

Captrust Financial Advisors boosted its position in Nutrien Ltd. (NYSE:NTRFree Report) by 1.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 738,514 shares of the company’s stock after buying an additional 12,079 shares during the quarter. Captrust Financial Advisors owned approximately 0.15% of Nutrien worth $43,359,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also bought and sold shares of the company. Root Financial Partners LLC purchased a new position in shares of Nutrien during the third quarter worth approximately $37,000. Geneos Wealth Management Inc. boosted its stake in shares of Nutrien by 42.4% in the 2nd quarter. Geneos Wealth Management Inc. now owns 735 shares of the company’s stock valued at $43,000 after purchasing an additional 219 shares in the last quarter. Fulcrum Asset Management LLP purchased a new stake in shares of Nutrien in the 3rd quarter valued at $46,000. Acadian Asset Management LLC bought a new position in shares of Nutrien during the 1st quarter valued at $54,000. Finally, Bessemer Group Inc. grew its holdings in shares of Nutrien by 27.7% during the 3rd quarter. Bessemer Group Inc. now owns 937 shares of the company’s stock valued at $55,000 after purchasing an additional 203 shares during the last quarter. 63.10% of the stock is currently owned by institutional investors.

Nutrien Trading Down 2.1%

NYSE:NTR opened at $77.92 on Thursday. The company has a 50-day moving average price of $71.26 and a 200-day moving average price of $63.06. The stock has a market cap of $37.48 billion, a price-to-earnings ratio of 16.72 and a beta of 0.70. The company has a current ratio of 1.34, a quick ratio of 0.70 and a debt-to-equity ratio of 0.37. Nutrien Ltd. has a 12 month low of $45.78 and a 12 month high of $85.36.

Nutrien (NYSE:NTRGet Free Report) last released its quarterly earnings results on Wednesday, February 18th. The company reported $0.83 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.87 by ($0.04). Nutrien had a return on equity of 8.41% and a net margin of 8.43%.The company had revenue of $5.12 billion during the quarter, compared to the consensus estimate of $5.26 billion. During the same period in the previous year, the company earned $0.31 earnings per share. Nutrien’s quarterly revenue was up 5.1% on a year-over-year basis. Equities analysts predict that Nutrien Ltd. will post 3.72 EPS for the current year.

Nutrien Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, April 16th. Shareholders of record on Tuesday, March 31st will be issued a dividend of $0.55 per share. This is a positive change from Nutrien’s previous quarterly dividend of $0.55. The ex-dividend date is Tuesday, March 31st. This represents a $2.20 dividend on an annualized basis and a dividend yield of 2.8%. Nutrien’s dividend payout ratio (DPR) is currently 46.78%.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on the stock. Zacks Research downgraded shares of Nutrien from a “strong-buy” rating to a “hold” rating in a research note on Monday, March 2nd. TD Securities raised their price objective on Nutrien from $80.00 to $81.00 and gave the company a “buy” rating in a research note on Tuesday, February 17th. Scotiabank lifted their price objective on Nutrien from $63.00 to $70.00 and gave the stock a “sector perform” rating in a report on Monday, February 2nd. Oppenheimer boosted their target price on Nutrien from $76.00 to $78.00 and gave the company an “outperform” rating in a research note on Thursday, February 26th. Finally, BMO Capital Markets increased their target price on Nutrien from $85.00 to $90.00 and gave the company an “outperform” rating in a report on Wednesday. Eleven analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $77.11.

View Our Latest Report on NTR

About Nutrien

(Free Report)

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.

Further Reading

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.